Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: |
Title | Tumor cell clearance reimagined. - CERo Therapeutics, |
Description | Our mission is to discover, translate, and deliver pioneering curative cell therapies that incorporate multiple forms of tumor clearance into single T |
Keywords | N/A |
WebSite | cero.bio |
Host IP | 173.236.227.128 |
Location | United States |
Site | Rank |
US$6,275,412
Last updated: 2023-05-02 13:36:21
cero.bio has Semrush global rank of 1,686,631. cero.bio has an estimated worth of US$ 6,275,412, based on its estimated Ads revenue. cero.bio receives approximately 724,086 unique visitors each day. Its web server is located in United States, with IP address 173.236.227.128. According to SiteAdvisor, cero.bio is safe to visit. |
Purchase/Sale Value | US$6,275,412 |
Daily Ads Revenue | US$5,793 |
Monthly Ads Revenue | US$173,781 |
Yearly Ads Revenue | US$2,085,368 |
Daily Unique Visitors | 48,273 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
cero.bio. | A | 299 | IP: 173.236.227.128 |
cero.bio. | NS | 14400 | NS Record: ns3.dreamhost.com. |
cero.bio. | NS | 14400 | NS Record: ns2.dreamhost.com. |
cero.bio. | NS | 14400 | NS Record: ns1.dreamhost.com. |
cero.bio. | MX | 300 | MX Record: 0 cero-bio.mail.protection.outlook.com. |
cero.bio. | TXT | 300 | TXT Record: MS=ms33839115 |
cero.bio. | TXT | 300 | TXT Record: v=verifydomain MS=8554799 |
cero.bio. | TXT | 300 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
cero.bio. | TXT | 300 | TXT Record: NETORGFT2553341.onmicrosoft.com |
About Science Our Science CER Mechanism of Action CER Technology Platform Related Literature Pipeline Careers News and Media Contact Tumor cell clearance reimagined. Our mission is to discover, translate, and deliver pioneering curative cell therapies that incorporate multiple forms of tumor clearance into single T cells. Our Science CERs explained Our technology uniquely integrates anti-tumor capabilities of both the innate and adaptive immune systems into a single T cell. › Exploiting a Natural Immune Process The CER platform We are advancing a CER T-cell platform that offers novel approaches for the treatment of both hematologic malignancies and solid tumors. › Therapeutic Potential of Our Platform Join the quest Our culture is mission-and innovation-driven towards bringing improved treatment options to patients. We are looking for talented and motivated individuals to join us in our quest. › Careers at CERo A differentiated mechanism of action for solid tumors We are excited to |
HTTP/1.1 301 Moved Permanently Date: Sun, 24 Oct 2021 23:39:50 GMT Server: Apache Location: https://cero.bio/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 date: Sun, 24 Oct 2021 23:39:50 GMT server: Apache last-modified: Tue, 19 Oct 2021 20:47:23 GMT etag: "4440-5cebac4c36889" accept-ranges: bytes content-length: 17472 cache-control: max-age=600 expires: Sun, 24 Oct 2021 23:49:50 GMT vary: Accept-Encoding,User-Agent content-type: text/html |
Domain Name: CERO.BIO Registry Domain ID: D503300000032852726-LRMS Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-12-01T12:24:32Z Creation Date: 2016-11-30T20:21:56Z Registry Expiry Date: 2021-11-30T20:21:56Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: +1.4806242505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Registrant Organization: Cero Registrant State/Province: California Registrant Country: US Name Server: NS15.DOMAINCONTROL.COM Name Server: NS16.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of WHOIS database: 2021-09-13T05:06:32Z <<< |